Q32 Bio Inc.
QTTB
$3.60
$0.195.43%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 3.56M | 280.00K | 265.00K | 10.55M | 14.35M |
| Gross Profit | -3.56M | -280.00K | -265.00K | -10.55M | -14.35M |
| SG&A Expenses | 4.02M | 4.01M | 5.10M | 3.98M | 4.47M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 7.58M | 9.17M | 11.30M | 14.53M | 18.81M |
| Operating Income | -7.58M | -9.17M | -11.30M | -14.53M | -18.81M |
| Income Before Tax | -7.39M | -9.49M | -11.03M | -15.79M | -17.60M |
| Income Tax Expenses | -- | -- | -- | -1.60M | -- |
| Earnings from Continuing Operations | -7.39M | -9.49M | -11.03M | -14.19M | -17.60M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.39M | -9.49M | -11.03M | -14.19M | -17.60M |
| EBIT | -7.58M | -9.17M | -11.30M | -14.53M | -18.81M |
| EBITDA | -7.49M | -9.08M | -11.19M | -14.41M | -18.69M |
| EPS Basic | -0.60 | -0.78 | -0.90 | -1.16 | -1.46 |
| Normalized Basic EPS | -0.38 | -0.49 | -0.51 | -1.63 | -0.91 |
| EPS Diluted | -0.60 | -0.78 | -0.90 | -1.16 | -1.46 |
| Normalized Diluted EPS | -0.38 | -0.49 | -0.51 | -1.63 | -0.91 |
| Average Basic Shares Outstanding | 12.24M | 12.20M | 12.20M | 12.18M | 12.08M |
| Average Diluted Shares Outstanding | 12.24M | 12.20M | 12.20M | 12.18M | 12.08M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |